Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Surg Oncol. 2012 Jan 17;106(1):24–30. doi: 10.1002/jso.23051

Figure 2. Occult tumor burden and the number of analytic lymph nodes assessed by RT-qPCR.

Figure 2

(A) Relationship between the number of lymph nodes harvested for histopathology and the number analyzed to quantify occult tumor burden (R=0.49, p<0.001). (B) Differential stratification of risk in patients with ≤12 or >12 lymph nodes evaluated by GUCY2C RT-qPCR to quantify occult tumor burden (p<0.001).